Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Prev Med. Author manuscript; available in PMC 2016 July 1.
Published in final edited form as:
PMCID: PMC4902718

Disparities in the prevalence of comorbidities among US adults by state Medicaid expansion status



About 92% of US older adults have at least one chronic disease or medical condition and 77% have at least two. Low-income and uninsured adults in particular experience a higher burden of comorbidities, and the Medicaid expansion provision of the Affordable Care Act was designed to improve access to healthcare in this population group. However, a significant number of US states have declined expansion. The purpose of this study is to determine the distribution of low-income and uninsured adults in expanded versus non-expanded states, and evaluate the prevalence of comorbidities in both groups.


Data from the 2013 Behavioral Risk Factor Surveillance System (BRFSS) dataset was analyzed, and Medicaid expansion status was assessed from the Center for Medicare and Medicaid Services report on State Medicaid and CHIP Income Eligibility Standards. Next, age adjusted mean number of comorbidities between expanded and non-expanded states was compared, with adjustment for socio-demographic differences.


Expanded states had a higher proportion of adults with income of at least $50,000 per year (39.6% vs. 35.5%, p < 0.01) and a lower proportion of individuals with no health insurance coverage (15.2% vs. 20.3%, p < 0.01) compared with non-expanded states. Among the uninsured, there was a higher proportion of obese (31.6% vs. 26.9%, p < 001), and higher average number of comorbidities (1.62 vs. 1.52, p < 0.01) in non-expanded states compared to expanded states. Overall, the prevalence of comorbidities was higher among BRFSS participants in states that did not expand Medicaid compared with those in expanded states.


States without Medicaid expansion have a greater proportion of poor, uninsured adults with more chronic diseases and conditions.

Keywords: Medicaid expansion, Affordable care act, Comorbidities, Disparities

1. Introduction

The high prevalence of chronic diseases and conditions among adults in the United States (US) is increasingly recognized as a major public health issue. Diseases such as coronary artery disease, diabetes, hypertension, dyslipidemia, chronic respiratory disorders, and psychiatric conditions are highly prevalent, with over 92% of older adults in the US having at least one condition, while 77% of older adults have at least two (National Council on Aging, 2015). Multiple studies also suggest that the presence of two or more chronic diseases or comorbidities, exert significant and negative influence on survival from major chronic diseases like cancer and cardiovascular disease, accounting for more than 1.5 million deaths annually and contributing to over 60% of all adult deaths (Heron, 2013). The negative impact of comorbidities on health also results in significant treatment delays, longer duration of hospitalization, poorer post-surgical outcomes, with prior studies showing that increased number of comorbidities reduces quality of life, and increases health care utilization and cost (Lankarani and Assari, 2015; Islam et al., 2015; Assari et al., 2013; Assari, 2014; Hollisaaz et al., 2007; Baumeister et al., 2005; Diederichs et al., 2010; Noohi et al., 2007; Buchacz et al., 2012; Long and Dagogo-Jack, 2011; Gijsen et al., 2001; Tammemagi et al., 2003). For instance, patients with diabetes and other comorbid conditions have total healthcare costs that are almost double those of patients without comorbidities (Pelletier et al., 2009).

The Affordable Care Act (ACA) of 2010 was designed to provide a comprehensive reform of health insurance programs beginning in 2010. Key aspects of the law include: the prohibition of healthcare coverage denial due to pre-existing conditions, provision of health insurance tax credits and subsidies to purchase health insurance, free preventive care, expansion of insurance coverage for adults with pre-existing conditions, and the expansion of Medicaid coverage to low-income (incomes up to 133% of the federal poverty level, approximately $15,500 for a single adult in 2014) and uninsured/underinsured individuals (Manchikanti et al., 2011; Sheen, 2012; Gostin and Garcia, 2012). Expanded access to medical care through the ACA could significantly improve the prevention of comorbidities through early lifestyle interventions, early detection and adequate treatment strategies. Furthermore, the expansion of Medicaid specifically addresses barriers to medical care often experienced by low-income, uninsured or under-insured adults as well as racial minorities who are also more likely to have comorbidities compared with other groups (Waits et al., 2014). Although the initial rollout of the ACA began in 2010, certain parts of the law, specifically Medicaid expansion, remain controversial. Since the start of Medicaid expansion in 2014, many US States have declined to participate due the reluctance of state governments and legislatures to further expand government services.

Multiple studies suggest that there are marked regional variation in risk behaviors and use of preventative health services (Kilmer et al., 2008; Cory et al., 2010), driven by differences in population characteristics such as demographics, socio-economic status (SES) and access to healthcare (Bauer et al., 2014; Braveman et al., 2011). In addition, racial minorities and low-income individuals tend to have a higher burden of diseases and comorbid conditions, and thus a greater need for healthcare services to manage those conditions (Kim et al., 2012; Shi et al., 2010). Therefore, if those states with greater healthcare need and higher proportion of low-income and racial minorities are less likely to participate in healthcare reform programs designed to provide better access to preventive healthcare, this population group will likely be left behind, and greater health disparities will be observed in the US. Healthcare reforms at the national level, focused on low-income and uninsured populations, has the potential to significantly reduce comorbidities, associated chronic diseases, and improve health outcomes in the US by eliminating barriers to adequate preventive care, regardless of race, income or geography. However, the benefit of such reforms is likely to be larger in areas with population at greatest need for healthcare.

In this study we analyze data from the Behavioral Risk Factor Surveillance System (BRFSS) to determine the socio-demographic and geographic distribution of comorbidities in the US, and assess whether states with a higher prevalence of comorbidities have elected to participate in the ACA Medicaid expansion program. Although the effect of the ACA provisions, including the Medicaid expansion program may not be fully realized for several years, identifying the burden of comorbidities in states that have declined or elected to participate in the program will provide key information for state and national policy-makers. By evaluating the burden of comorbidities among individuals in both groups, we expect to identify groups where expanded healthcare coverage may provide the greatest benefit by improving health promotion, disease prevention and affordable care.

2. Methods

2.1. Study design & data source

We performed a cross-sectional study of US adults using data from the 2013 Behavioral Risk Factor Surveillance System (BRFSS) dataset (Center for Disease Control and Prevention, 2013) The BRFSS is an ongoing, state-based, random-digit-dialed telephone survey of non-institutionalized adults residing in the US. The BRFSS routinely collects data on health risk behaviors, chronic diseases and conditions in all US states and territories. All 483,865 BRFSS participants ages 18 years and older from the fifty US states and the District of Columbia were included in this analysis.

2.2. Main study variables

Our main predictor of interest was Medicaid expansion status, categorized as expanded or non-expanded based on each state's status on adoption of the ACA. Data on state expansion status was obtained from the Center for Medicare and Medicaid Services report on State Medicaid and CHIP Income Eligibility Standards, based on state decisions as of January 1, 2015 (Services CfMaM, 2014). Our main outcome of interest was the number of diagnosed chronic diseases or conditions self-reported by individuals, including: high blood pressure, high cholesterol, prior diagnosis of heart attack, angina, stroke, asthma, any cancer (except skin cancer), skin cancer, COPD, arthritis, depression, kidney disease and diabetes. We summed the total number of comorbidities for each individual, and estimated the state-level mean number of comorbidities by expansion status.

2.3. Other covariates

We included self-reported individual socio-demographic variables such as age, race/ethnicity, marital status and education. Health insurance status was based on individual responses to the question: ‘Do you have any kind of health care coverage, including health insurance, prepaid plans such as HMOs or government plans such as Medicare, or Indian Health Service?’ Uninsured individuals were defined as those who reported currently not being covered by any health insurance or health coverage plan. We also controlled for differences in prevalence of comorbidities based on other measures of healthcare access such as having a primary doctor, and time since last visit to the doctor. Income was defined based on self-reported annual household income from all sources, and low-income individuals were categorized as those with annual household income of $25,000 per year or less. BMI data was obtained from the BRFSS dataset as a calculated variable derived from self-reported weight and height information.

2.4. Ethics statement

This study was considered exempt by the institutional review board of the University of Alabama at Birmingham, as we used existing secondary data that are publicly available and non-identifiable.

2.5. Statistical analysis

We performed all statistical analyses and geographic mapping using SAS version 9.4, QGIS version 2.8.1-Wien, and GeoDa version We considered p-values less than or equal 0.05 as statistically significant. We applied statistical weights to account for clustering and sampling design for the BRFSS. We compared socio-demographic, socioeconomic and healthcare access variables between expanded and non-expanded states using chi-square tests for categorical characteristics and ANOVA for continuous characteristics. To estimate the age-adjusted state-level mean comorbidities, we sequentially performed three generalized linear models with mean number of comorbidities as the outcome, state expansion status as the main exposure, and accounted for strata and sampling weights. Other covariates included in three statistical models were; age, gender and race in model 1; age, gender, race and BMI in model 2; age, gender, race, BMI, household income, and healthcare access variables in model 3.

3. Results

A total of 483,865 individuals were included in the analysis, with 48.18% (n = 233,130) in non-expanded states and 51.82% (n = 250,735) in expanded states (Table 1, Fig. 1). Except for age, there were statistically significant differences by expansion status with all other study covariates (p < 0.001). Expanded states had a lower proportion of Blacks compared with non-expanded states (7.8% vs. 12.6%), and expanded states had a higher proportion of adults with at least a college degree (37.5% vs. 32.6%). In addition, expanded states had a higher proportion of adults with income of at least $50,000 per year (39.6% vs. 35.5%) compared with non-expanded states. Expanded states had a lower proportion of individuals with no health insurance coverage compared with non-expanded states (15.2% vs. 20.3%), a lower proportion of adults with no regular medical doctor (15.3% vs. 17.1%), and a lower proportion of adults who reported not visiting any doctor for at least 5 years (7.9% vs. 9%). Overall, individuals in expanded states had a lower mean number of comorbidities compared with those in non-expanded states (2.10 vs. 2.16, p < 0.001).

Fig. 1
State Medicaid expansion status and age-adjusted mean number of comorbidities.
Table 1
Comparison of socio-demographic and healthcare access characteristics by healthcare expansion status.

There were clear geographic trends in both Medicaid expansion status and mean number of comorbidities (Fig. 1). The majority of Southeastern US States (except Arkansas, Kentucky and West Virginia) did not expand Medicaid, but these states had the highest burden of comorbidities, with a majority of adult populations in the third and fourth quartile of mean prevalence of comorbidities. Several Northeastern states, including Michigan, Ohio and Pennsylvania did expand Medicaid and also had adult populations with a high burden of comorbidities. Most Western US states (except Washington, Oregon and Arizona) had lower mean comorbidities, and expanded Medicaid. Data on the age-adjusted mean number of comorbidities in each of the 50 US states stratified by race/ethnicity and gender, and a map depicting number of comorbidities and Medicaid expansion status is provided in supplemental tables and maps (see Tables 1–5 and Figs. 1–4 in Ref Akinyemiju and Moore (2015)).

When the analysis was restricted to uninsured and low-income participants (Table 2), there were significant differences in the proportion of obese individuals, access to healthcare and average number of comorbidities (p < 0.05). Among 54, 534 total uninsured individuals, there was a higher proportion of obese in non-expanded states compared to expanded states (31.6% vs. 26.9%). In addition, average number of comorbidities was significantly higher among the uninsured in non-expanded states, compared with uninsured in expanded states (1.62 vs. 1.52, p < 0.001). Similar patterns were observed among low-income participants. Among 124, 386 low-income individuals, a higher proportion of obese individuals were in non-expanded states (34% vs. 31%), and the average number of comorbidities was significantly higher among low-income residents of non-expanded states (2.51 vs. 2.40, p < 0.001). Regardless of expansion status, low-income individuals had a greater prevalence of comorbidities compared with uninsured individuals or the entire study population. After accounting for socio-demographic (model 1), BMI (model 2) and socio-economic status and access to healthcare (model 3), we still observed significantly higher mean number of comorbidities among participants residing in non-expanded states (β mean number of comorbidities: 0.037, p-value = <0.001) compared with those in expanded states (Table 3).

Table 2
Prevalence of comorbidities among uninsured and low-income populations by ACA expansion status.
Table 3
Multivariable association of ACA Medicaid expansion status and mean number of comorbidities.

4. Discussion

We evaluated the prevalence of comorbidities among US adults using the 2013 BRFSS data, and compared Medicaid expanded states with non-expanded states. We observed no difference in the proportion of older adults (ages 65 years and older) between the two groups, but observed that non-expanded states had significantly higher proportions of adults who were Black, had less than high school education and were currently uninsured compared with expanded states. When limited to low-income and uninsured adults, non-expanded states had a higher proportion of obese individuals with a higher number of comorbidities on average compared with expanded states. Overall, individuals in non-expanded states had significantly higher number of comorbidities compared with those in expanded states, and this difference remained even after accounting for socio-demographic, socio-economic and healthcare access differences between groups.

Multiple studies have documented the negative impact of comorbidities on several aspects of health, ranging from psychological outcomes to mortality (Assari et al., 2013; Baumeister et al., 2005; Buchacz et al., 2012; Gijsen et al., 2001; Islam et al., 2015; Lankarani and Assari, 2015; Tammemagi et al., 2003). For instance, Lankarani and Assari (2015) reported that comorbidities are associated with major depressive disorder (Lankarani and Assari, 2015), and Islam et al. (2015) reported that after adjustment for age, sex, gender, race, and histologic type, comorbidities are associated with lower lung cancer survival among cancer patients (Islam et al., 2015). Despite these observations, significant socio-economic and healthcare access disparity exists in the US healthcare system, with poor and uninsured individuals who lack access to reliable healthcare also more likely to engage in harmful health behavior such as smoking, poor nutrition and low physical activity (Waits et al., 2014). Our results further show that individuals who are poor, uninsured, and belong to racial minority groups in the US are more likely to reside in non-expanded states. As a result of the underlying demographic (racial minorities), financial (low-income adults) and health (number of comorbidities) differences that exists currently between expanded and non-expanded states, it is likely that health disparities will actually widen in the coming years as individuals in states with Medicaid expansion (with higher income and less comorbidities on average) gain even better access to better preventive and medical care.

Few federal government-funded programs exist to assist low-income and uninsured adults with specific health needs; an example is the Breast and Cervical Cancer Early Detection (BCCED) Program for breast and cervical cancer screening (Miller et al., 2014; Liu et al., 2005). However, there are few federally funded programs focused on addressing highly prevalent chronic health issues such as diabetes or heart disease. The limited success of the BCCED program in reaching and screening low-income women provides some evidence that a singular focus on one aspect of health i.e. cancer screening, without a comprehensive approach that includes other health issues is likely to be inadequate, especially in low income populations where such care is most needed. (Tangka et al., 2015, 2010) Furthermore, although low-income and uninsured individuals in certain states may have access to safety net clinics, these are often severely limited in resources, capacity and scope. Medicaid expansion, on the other hand, by improving access to primary care and preventive health services such as high blood pressure and diabetes management, would constitute a comprehensive healthcare resource for sicker, poorer populations who would otherwise forgo care or obtain uncompensated care in emergency rooms.

Beyond the immediate benefit to individuals who will obtain better quality, more affordable health insurance, Medicaid expansion through the ACA is projected to provide significant economic benefits to states by reducing the amount of money spent on uncompensated care at hospitals and safety net clinics for uninsured patients (Ayanian, 2013; Holahan and Dorn, 2013). In addition, other aspects of the ACA such as the individual mandate and prohibition of exclusions based on pre-existing conditions already provide significant benefits to individuals who are able to afford health insurance, either through an employer or on the health insurance exchange market. Unfortunately, states that forgo Medicaid expansion will likely continue to experience a greater burden on individual health and the economy, associated with having a sicker, poorer population, and individuals with incomes below 100% of federal poverty will be ineligible for subsidies or Medicaid coverage beyond current eligibility levels, dramatically increasing insurance gaps and reducing revenue for hospitals.

Our finding that adjusting for household income and access to healthcare did not eliminate the significant association between expansion status and prevalence of comorbidities suggest that other factors, such as health behaviors like smoking, alcohol and diet, may be more important determinants of comorbidities. Other studies have shown that lower socio-economic status may be associated with poor health behavior, including smoking, alcohol, lack of physical activity and obesity, as well as poorer management of chronic diseases such as high blood pressure and diabetes (White et al., 2015; Giles-Corti and Donovan, 2002; Slater and Carlton, 1985; Piper et al., 2015). Therefore, if poor health behaviors can be eliminated (e.g. through smoking cessation programs, health education campaigns to encourage physical activity and healthy diets), and preventive care encouraged without Medicaid expansion, then disparities in comorbidities between expanded and non-expanded states may not be inevitable. States could increase allocation of funds for safety net clinics, community healthcare centers and rural health clinics, and/or reduce or eliminate strict income eligibility criteria for such clinics. However, it remains to be seen whether policy makers in non-expanded states that are reluctant to commit funds and resources to Medicaid expansion (although the full cost of the program is provided by the federal government for the first several years), will be willing to fund alternative programs designed to improve the health of their vulnerable population.

There are several strengths in the current analysis. First, the use of the BRFSS data provides high-quality, nationally representative data on recent demographic, socioeconomic and healthcare access data. Secondly, all statistical analyses accounted for survey weights to account for the study design, and mean response rates by expansion status has been shown to be similar (45% in expansion states versus 47% in non-expansion states) (Sabik et al., 2015). There are also a few limitations to consider. First, the use of self-reported measures of chronic disease and conditions is a potential limitation, as diagnoses are not confirmed through medical records. However, the BRFSS is conducted by trained interviewers and focused on a wide range of health topics, therefore individual measures are unlikely to be highly biased. Second, while the ACA was signed into law during the spring of 2010, many of the provisions did not go into effect until late 2014 (Manchikanti et al., 2011). The full effect of the ACA, and its key components such as Medicaid expansion will likely not be observable for several more years. However, by conducting analysis on data prior to expansion, we are able to determine differences and similarities in expanded versus non-expanded states at baseline, pending the release of future years of data to assess changes over time. Therefore, the true association between Medicaid expansion and comorbidities has not been captured in our analysis using the 2013 BRFSS data. Future studies will be needed to determine the health disparities, if any, that may occur subsequent to Medicaid expansion program. For instance, comparing US states with a high prevalence of comorbidities that did not expand Medicaid (e.g. Mississippi, Alabama, Tennessee, and South Carolina) with those that did expand Medicaid (e.g. Michigan, Ohio and Pennsylvania) after adjusting for socio-demographic differences, will provide a wealth of information on the potential for federally-mandated social programs to influence individual health.

5. Conclusions

States that did not participate in the ACA Medicaid expansion program experience a higher burden of comorbidities compared with states that did participate, and this finding was not accounted for by differences in socio-economic status or healthcare access. Negative health behaviors and exposures prevalent in non-expanded states may propagate this difference in the coming decades as individuals in expanded states obtain better access to preventive and medical care, unless other programs designed to improve prevention and management of disease are created in non-expanded states.


Financial support and acknowledgements

Mr. Moore received grant support from grant R25 CA47888 by the National Cancer Institute, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.


Transparency document

The Transparency document associated with this article can be found, in online version.


  • Akinyemiju T, Moore JX. Descriptive Analysis of Prevalence of Comorbidities by State and Medicaid Expansion Status. 2015 (Data in Brief In press)
  • Assari S. Cross-county variation in additive effects of socio-economics, health behaviors, and comorbidities on subjective health of patients with diabetes. J. Diabetes Metab. Disord. 2014;13(36):11. [PMC free article] [PubMed]
  • Assari S, Lankarani MM, Ahmadi K. Comorbidity influences multiple aspects of well-being of patients with ischemic heart disease. Int. Cardiovasc. Res. J. 2013;7(4):118–123. [PMC free article] [PubMed]
  • Ayanian JZ. Michigan's approach to Medicaid expansion and reform. N. Engl. J. Med. 2013;369(19):1773–1775. [PubMed]
  • Bauer UE, Briss PA, Goodman RA, Bowman BA. Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet. 2014;384(9937):45–52. [PubMed]
  • Baumeister H, Balke K, Harter M. Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. J. Clin. Epidemiol. 2005;58:1090–1100. [PubMed]
  • Braveman PA, Kumanyika S, Fielding J, Laveist T, Borrell LN, Manderscheid R, Troutman A. Health disparities and health equity: the issue is justice. Am. J. Public Health. 2011;101(Suppl):S149–S155. [PubMed]
  • Buchacz K, Baker RK, Palella FJ, Shaw L, Patel P, Lichtenstein KA, Chmiel JS, Vellozzi C, Debes R, Henry K, Overton ET, Bush TJ, Tedaldi E, Carpenter C, Mayer KH, Brooks JT. Outpatients Study Investigators, H.I.V. Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir. Ther. 2012 [PubMed]
  • Center for Disease Control and Prevention. Behavioral Risk Factor Surveillance System (BRFSS) 2013 Survey Data. [Accessed July 21 2015];2013
  • Cory S, Ussery-Hall A, Griffin-Blake S, Easton A, Vigeant J, Balluz L, Garvin W, Greenlund K. Centers for Disease Control and Prevention (CDC) Prevalence of selected risk behaviors and chronic diseases and conditions-steps communities, United States, 2006–2007. MMWR Surveill. Summ. 2010;59(8):1–37. [PubMed]
  • Diederichs C, Berger K, Bartels DB. The measurement of multiple chronic diseases — a systematic review on existing multimorbidity indices. J. Gerontol. 2010;66A(3):301–311. [PubMed]
  • Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GAM. Causes and consequences of comorbidity: a review. J. Clin. Epidemiol. 2001;54:661–674. [PubMed]
  • Giles-Corti B, Donovan RJ. Socioeconomic status differences in recreational physical activity levels and real and perceived access to a supportive physical environment. Prev. Med. 2002;35(6):601–611. [PubMed]
  • Gostin LO, Garcia KK. Affordable Care Act litigation: the Supreme Court and the future of health care reform. JAMA. 2012;307(4):369–370. [PubMed]
  • Heron M. Deaths: leading causes for 2010. Natl. Vital Stat. Rep. 2013;62(6):97. [PubMed]
  • Holahan JBM, Dorn S. The Henry J. Washington, DC: Kaiser Family Foundation; 2013. The Cost of not Expanding Medicaid. The Kaiser Commission on Medicaid and the Uninsured.
  • Hollisaaz MT, Lorgard-Dezfuli-Nezad M, Assari S, Hafezie R, Ebrahiminia M. Medical comorbidities after renal transplantation. Transplant. Proc. 2007;39:1048–1050. [PubMed]
  • Islam KMM, Jiang X, Anggondowati T, Lin G, Ganti AK. Comorbidity and survival in lung cancer patients. Cancer Epidemiol. Biomark. Prev. 2015;24(7):1079–1085.–9965.EPI-15-0036. [PubMed]
  • Kilmer G, Roberts H, Hughes E, Li Y, Valluru B, Fan A, Giles W, Mokdad A, Jiles R. Centers for Disease Control and Prevention (CDC) Surveillance of certain health behaviors and conditions among states and selected local areas–Behavioral Risk Factor Surveillance System (BRFSS), United States, 2006. MMWR Surveill. Summ. 2008;57(7):1–188. [PubMed]
  • Kim G, Ford KL, Chiriboga DA, Sorkin DH. Racial and ethnic disparities in healthcare use, delayed care, and management of diabetes mellitus in older adults in California. J. Am. Geriatr. Soc. 2012;60(12):2319–2325. [PubMed]
  • Lankarani MM, Assari S. Association between number of comorbid medical conditions and depression among individuals with diabetes; race and ethnic variations. J. Diabetes Metab. Disord. 2015;14(56):8. [PMC free article] [PubMed]
  • Liu MJ, Hawk H, Gershman ST, Smith SM, Karacek R, Woodford ML, Ayanian JZ. The effects of a National Breast and Cervical Cancer Early Detection Program on social disparities in breast cancer diagnosis and treatment in Massachusetts. Cancer Causes Control. 2005;16(1):27–33. [PubMed]
  • Long AN, Dagogo-Jack S. The comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J. Clin. Hypertens. (Greenwich) 2011;13(4):244–251. [PMC free article] [PubMed]
  • Manchikanti L, Caraway D, Parr AT, Fellows B, Hirsch JA. Patient protection and affordable care act of 2010: reforming the health care reform for the new decade. Pain Physician. 2011;14:E36–E67. [PubMed]
  • Miller JW, Plescia M, Ekwueme DU. Public health national approach to reducing breast and cervical cancer disparities. Cancer. 2014;120(Suppl. 16):2537–2539. [PMC free article] [PubMed]
  • National Council on Aging. Fact Sheet — healthy aging. [Accessed July 21 2015];2015
  • Noohi S, Khaghani-Zadeh M, Javadipour S, Assari M, Najafi M, Ebrahiminia M, Pourfaziani V. Anxiety and depression are correlated with higher morbidity after kidney transplantation. Transplant. Proc. 2007;39:1074–1078. [PubMed]
  • Pelletier EM, Shim B, Ben-Joseph R, Caro JJ. Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis. PharmacoEconomics. 2009;27(6):479–490. [PubMed]
  • Piper CN, Polite-Middleton T, Chalakalal S, Sebastion N, Martin F. Race, socioeconomic status, and rurality influences on type 2 diabetes management among North Carolina adults. Ethn. Dis. 2015;25(1):46–51. [PubMed]
  • Sabik LM, Tarazi WW, Bradley CJ. State Medicaid expansion decisions and disparities in women's cancer screening. Am. J. Prev. Med. 2015;48(1):98–103. [PMC free article] [PubMed]
  • Services CfMaM. Centers for Medicare and Medicaid Services; 2014. [Accessed June 5th, 2015 2015]. State Medicaid and CHIP Income Eligibility Standards.
  • Sheen E. Supreme court review of the affordable care act: the future of health care reform and practice of gastroenterology. Dig. Dis. Sci. 2012;57:1735–1741. [PubMed]
  • Shi L, Lebrun LA, Tsai J. Access to medical care, dental care, and prescription drugs: the roles of race/ethnicity, health insurance, and income. South Med. J. 2010;103(6):509–516. [PubMed]
  • Slater C, Carlton B. Behavior, lifestyle, and socioeconomic variables as determinants of health status: implications for health policy development. Am. J. Prev. Med. 1985;1(5):25–33. [PubMed]
  • Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Impact of comoborbidity on lung cancer survival. Int. J. Cancer. 2003;103:792–802. [PubMed]
  • Tangka FK, O'Hara B, Gardner JG, Turner J, Royalty J, Shaw K, Sabatino S, Hall IJ, Coates RJ. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004–2006. Cancer Causes Control. 2010;21(7):1081–1090. [PubMed]
  • Tangka FK, Howard DH, Royalty J, Dalzell LP, Miller J, O'Hara BJ, Sabatino SA, Joseph K, Kenney K, Guy GP, Jr, Hall IJ. Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997–2012. Cancer Causes Control. 2015;26(5):671–686. [PMC free article] [PubMed]
  • Waits SA, Reames BN, Sheetz KH, Englesbe MJ, Campbell DA., Jr Anticipating the effects of Medicaid expansion on surgical care. JAMA Surg. 2014;149(7):745–747. [PMC free article] [PubMed]
  • White TJ, Redner R, Bunn JY, Higgins ST. Do socioeconomic risk factors for cigarette smoking extend to smokeless tobacco use? Nicotine Tob. Res. 2015 [PMC free article] [PubMed]